Kupke, A.; Volz, A.; Dietzel, E.; Freudenstein, A.; Schmidt, J.; Shams-Eldin, H.; Jany, S.; Sauerhering, L.; Krähling, V.; Gellhorn Serra, M.;
et al. Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines 2022, 10, 533.
https://doi.org/10.3390/vaccines10040533
AMA Style
Kupke A, Volz A, Dietzel E, Freudenstein A, Schmidt J, Shams-Eldin H, Jany S, Sauerhering L, Krähling V, Gellhorn Serra M,
et al. Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines. 2022; 10(4):533.
https://doi.org/10.3390/vaccines10040533
Chicago/Turabian Style
Kupke, Alexandra, Asisa Volz, Erik Dietzel, Astrid Freudenstein, Jörg Schmidt, Hosam Shams-Eldin, Sylvia Jany, Lucie Sauerhering, Verena Krähling, Michelle Gellhorn Serra,
and et al. 2022. "Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein" Vaccines 10, no. 4: 533.
https://doi.org/10.3390/vaccines10040533
APA Style
Kupke, A., Volz, A., Dietzel, E., Freudenstein, A., Schmidt, J., Shams-Eldin, H., Jany, S., Sauerhering, L., Krähling, V., Gellhorn Serra, M., Herden, C., Eickmann, M., Becker, S., & Sutter, G.
(2022). Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines, 10(4), 533.
https://doi.org/10.3390/vaccines10040533
